2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home »
- Clinical Resources Search »
- PQI: Exercise During Cancer Treatment
Exercise During Cancer Treatment
About this PQI
Not only does exercise during cancer treatment decrease the number and/or severity of side effects, but it also assists in recovery from treatment and in some cases can lower the risk of cancer recurrence. Exercise is also vital for the maintenance and/or improvement of physical functioning, mental health, and quality of life during treatment. Per guidelines, it is recommended that all individuals diagnosed with cancer avoid inactivity, improve general health, and aim to achieve the current physical activity guidelines for healthy populations (≥150 min/week aerobic exercise and ≥2 days/week strength training as well as incorporating balance and flexibility exercise).1,2,3 This is why it is vital that these individuals are working with proper exercise professionals to ensure that they are getting the appropriate modes and intensities of exercise to best help them meet those recommendations. If individuals are unable to meet recommended targets upon starting exercise, the appropriately qualified exercise professionals would assist them to meet these recommendations.

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 09/17/2025
PQI: Revumenib (Revuforj) for the Management of Acute Leukemia
Author: Tracelyn Freeman, PharmD, BCOP
Last Updated: 09/17/2025
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 09/17/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 09/17/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management
Author: Atlanticare Cancer Care Institute | Cancer Specialists of North Florida
Last Updated: 09/17/2025
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Huntsman Cancer Institute | University Hospitals
Last Updated: 09/17/2025
PQI in Action: Fruquintinib (Fruzaqla®)
Author: Florida Cancer Specialists & Research Institute | Atlanticare Cancer Care Institute
Last Updated: 09/17/2025
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 09/17/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S9 E4: Advancing Pharmacogenomics in Oncology
Author: Ginger Blackmon, PharmD | Soni Tuteja
Last Updated: 09/17/2025
S9 E3: Firefighter Health & Cancer Prevention
Author: Ginger Blackmon, PharmD | Tim Thompson
Last Updated: 09/17/2025
S9 E2: Love Languages in Cancer Care
Author: Ginger Blackmon, PharmD | Jenny Hoang, PharmD
Last Updated: 09/17/2025
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 09/17/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 09/17/2025
Treatment Support Kit: Mirdametinib
Last Updated: 09/17/2025
Treatment Support Kit: Abemaciclib
Last Updated: 09/17/2025
Treatment Support Kit: Temozolomide
Last Updated: 09/17/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 09/17/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 09/17/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 09/17/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 09/17/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 09/17/2025
The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program
Author: Ginger Blackmon, PharmD | Salvatore Bottiglieri, PharmD, BCOP
Last Updated: 09/17/2025
The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings
Author: Ginger Blackmon, PharmD | Shana O. Ntiri, MD, MPH, FAAFP,
Last Updated: 09/17/2025
The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team
Author: Ginger Blackmon, PharmD | April Hallatt, BSN, RN, OCN
Last Updated: 09/17/2025
PQI
PQI
PQI Podcast
PQI Podcast
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 09/17/2025
PQI: Bone Health and the Cancer Patient
Author: Nina DiPierro Pharm.D. BCOP, Florida Cancer Specialists and Research Institute | Farishta Manzoor, PharmD, Hartford HealthCare Cancer Institute
Last Updated: 09/17/2025
The PQI Podcast S4 Ep 5: Role of Oncology Social Worker
Author: Ginger Blackmon, PharmD | Neshama Marcus, LMSW
Last Updated: 09/17/2025
The PQI Podcast S4 Ep 6 : Community Pharmacy and Ohio Board of Pharmacy
Author: Ginger Blackmon, PharmD | Christine Pfaff, RPh
Last Updated: 09/17/2025
PQI
PQI Podcast
PQI Podcast
PQI in Action
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 09/17/2025
S9 E4: Advancing Pharmacogenomics in Oncology
Author: Ginger Blackmon, PharmD | Soni Tuteja
Last Updated: 09/17/2025
S9 E3: Firefighter Health & Cancer Prevention
Author: Ginger Blackmon, PharmD | Tim Thompson
Last Updated: 09/17/2025
PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management
Author: Atlanticare Cancer Care Institute | Cancer Specialists of North Florida
Last Updated: 09/17/2025